|1.||Becker, David J: 4 articles (02/2011 - 06/2009)|
|2.||Gordon, Ram Y: 4 articles (02/2011 - 06/2009)|
|3.||Zhang, Yanjun: 3 articles (04/2011 - 07/2008)|
|4.||Seeram, Navindra P: 3 articles (04/2011 - 07/2008)|
|5.||Heber, David: 3 articles (04/2011 - 07/2008)|
|6.||Hong, Mee Young: 3 articles (04/2011 - 07/2008)|
|7.||Liu, Ling: 3 articles (02/2007 - 06/2003)|
|8.||Ruscica, Massimiliano: 2 articles (03/2015 - 01/2014)|
|9.||Macchi, Chiara: 2 articles (03/2015 - 01/2014)|
|10.||Magni, Paolo: 2 articles (03/2015 - 01/2014)|
01/01/2014 - "To explore whether red yeast rice is a safe and effective alternative approach for dyslipidemia. "
02/01/2002 - "A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia."
01/01/2014 - "However, further long-term, rigorously designed randomized controlled trials are still warranted before red yeast rice could be recommended to patients with dyslipidemia, especially as an alternative to statins."
06/01/2011 - "Aim of the study was to evaluate, in a group of children affected by primary dyslipidemia, the efficacy, tolerability and safety of a short-term treatment with a dietary supplement containing red yeast rice extract and policosanols. "
06/16/2009 - "Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial."
06/01/2009 - "Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia."
01/01/2006 - "Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials."
05/01/2012 - "Red yeast rice: efficacy and tolerability of Monascus purpureus yeast, for treatment of hyperlipidemia in patients with statin-associated myalgias."
02/01/2011 - "Therefore, until red yeast rice products are regulated and standardized, physicians and patients should be cautious in recommending this promising alternative therapy for hyperlipidemia."
10/25/2010 - "Red yeast rice (RYR) is a widely available dietary supplement used by millions of patients as an alternative therapy for hyperlipidemia. "
11/01/2015 - "In the short term, a combined nutraceutical containing red yeast rice and PUFAs is well tolerated and efficacious in reducing plasma lipid levels in subjects affected by primary polygenic hypercholesterolemia and metabolic syndrome. "
02/01/2011 - "Red yeast rice is an ancient Chinese dietary staple and medication used by millions of patients as an alternative therapy for hypercholesterolemia. "
12/01/2015 - "Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study."
11/01/2013 - "To investigate the effect of a natural cholesterol-lowering supplement (NCLS) containing red yeast rice, policosanols and artichoke leaf extracts on blood lipid concentrations as well as on safety parameters when given over 16 weeks in 100 volunteers with untreated moderate hypercholesterolemia, in a randomized, double-blind, placebo-controlled trial. "
12/01/2015 - "We aimed to investigate the efficacy and the safety of a nutraceutical combination consisting mainly of 200 mg red yeast rice extract (equivalent to 3 mg monacolins), 500 mg berberine, and 10 mg policosanols (MBP-NC) in patients with low-moderate risk hypercholesterolemia. "
07/01/2013 - "One large randomized controlled study from China found that red yeast rice significantly improved risk of major adverse cardiovascular events and overall survival in patients following myocardial infarction. "
08/20/2008 - "CCSPS (4870 patients, follow-up 4 years), a secondary prevention trial using xuezhikang, a commercial red yeast rice preparation, produced a 46% reduction in nonfatal myocardial infarction and coronary death. "
06/15/2008 - "This multicenter study was conducted to determine the effects of Xuezhikang (XZK), a partially purified extract of red yeast rice, on lipoprotein and CV end points in Chinese patients who experienced a previous myocardial infarction. "
02/01/2015 - "In patients with known coronary artery disease and dyslipidemia (secondary prevention), therapy with red-yeast rice extract containing naturally-occurring lovastatin is associated with a 30% reduction in coronary heart disease (CHD) mortality and a 60% reduction in myocardial infarction (MI), similar to the effect of statin medications. "
|5.||Coronary Disease (Coronary Heart Disease)
02/01/2007 - "Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS)."
08/24/2004 - "Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease."
06/01/2003 - "Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease."
01/01/2015 - "Monacolin K, an extract of red yeast rice (RYR, Hongqu), plays important roles in the management of dyslipidemia, coronary heart disease, and diabetes. "
01/01/2012 - "A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia."
|1.||red yeast rice
|8.||Biological Markers (Surrogate Marker)
|2.||Transplantation (Transplant Recipients)
|4.||Chinese Traditional Medicine (Traditional Chinese Medicine)